Zobrazeno 1 - 10
of 690
pro vyhledávání: '"Anti factor xa"'
Autor:
Yasaman Pirahanchi, Kristin Salottolo, Christian Burrell, Xu Tang, David Bar-Or, Russell Bartt
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
ObjectiveThere are no studies to date that examine the association between anti-factor-Xa (AFXa)-based heparin monitoring and clinical outcomes in the setting of cerebral venous thrombosis (CVT).MethodsThis pilot study included adults aged ≥18 admi
Externí odkaz:
https://doaj.org/article/1d9a1a7da6664bfe8361c941464c0dfc
Autor:
Mauricio Concha, Lizhen Xu, MacKenzie Horn, Tomoyuki Ohara, Juliet Nakamya, Jan Beyer‐Westendorf, Ashkan Shoamanesh, Alexander Cohen, Per Ladenvall, Stuart J. Connolly, Andrew M. Demchuk
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 4, Iss 1 (2024)
Background Andexanet alfa, a specific reversal agent for factor Xa inhibitors, resulted in effective hemostasis in 79% of patients with intracranial bleeding in the ANNEXA‐4 (Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor
Externí odkaz:
https://doaj.org/article/9afe5c2bf3dd4bf3923c253ead8387eb
Autor:
Renata Jurema Medeiros, Nathália Pessoa Gonçalves, Magno Maciel Magalhães, João Ferreira Martins, Tiago Savignon Cardoso Machado
Publikováno v:
Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, Vol 11 (2023)
Introduction: Heparin is a drug that has anticoagulant activity, binding to antithrombin and accelerating the rate of inhibition of several proteases involved in the coagulation process. In the 2000s, the world market faced a troubled period regardin
Externí odkaz:
https://doaj.org/article/53ba1a25eff74db089bc9fe41a155c13
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundAnti-factor Xa activity has been suggested as a surrogate parameter for judging the effectiveness of pharmacological thromboprophylaxis with low molecular weight heparins in critically ill patients. However, this practice is not supported b
Externí odkaz:
https://doaj.org/article/4b134a693d6f487c80049556fc6fc570
Publikováno v:
Ведомости Научного центра экспертизы средств медицинского применения, Vol 11, Iss 1, Pp 24-35 (2021)
Abstract. Medicinal products of natural origin are widely used by virtue of their pharmacological efficacy and relative safety. Chemical composition of such medicines is usually complex, they may be represented by heteropolymers or mixtures containin
Externí odkaz:
https://doaj.org/article/58dcd174adc948b0a1a8060784d9ee58
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 3, p 1161 (2023)
This study aims to evaluate the efficacy of anti-factor Xa activity (aFXa) in predicting ecchymosis after total knee arthroplasty (TKA). One hundred and two unilateral primary TKA patients were recruited consecutively in this prospective observationa
Externí odkaz:
https://doaj.org/article/e03f5dd832ed4644a92f14bd84d02409
Publikováno v:
Talanta Open, Vol 4, Iss , Pp 100059- (2021)
The feasibility of in vivo real-time monitoring of anti-factor Xa level had been explored using an integrated microdialysis-coupled microfluidic system. By customizing the dialysis membrane and utilizing a fluorogenic substrate, the performance of th
Externí odkaz:
https://doaj.org/article/662bfa737457418d86271655d4c153d3